The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal officials began reviewing ...

Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just ...

George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...

Dr George Tidmarsh, head of the FDA's drug centre, resigned after federal officials began investigating serious personal conduct concerns. Aurinia Pharmaceuticals filed a lawsuit, accusing him of ...

The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.

FDA CDER Director George Tidmarsh resigns over controversy involving Aurinia Pharma board chair and lupus drug criticism. Read more here.

The director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...

George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug Evaluation and Research, resigned Nov. 2 after being placed on administrative leave, The New York Times reported Nov. 2. Dr. Tidmarsh ...

The head of the U.S. Food and Drug Administration’s drug centre abruptly resigned Sunday after federal officials began ...